Turkish COVID-19 vaccine starts Phase 3 clinical trials

Turkey is developing a domestic vaccine named "Turkovac" by President Tayyip Erdogan. The vaccine entered into phase three clinical trials on Tuesday and should be available for use by the end of the year.

"Turkovac" should be available by the end of the year, country's president says

The "Turkovac" vaccine enters into Phase 3 clinical trials today and is anticipated to be ready for public consumption by the end of the year. President Tayyip Erdogan of Turkey emphasized the need for domestic manufacturing of vaccines due to the unpredictability of the COVID-19 variants. (AP Photo/Luca Bruno) (Luca Bruno/The Associated Press) (Luca Bruno/The Associated Press)

Turkey has kicked off phase three clinical trials for its COVID-19 vaccine, named "Turkovac" by President Tayyip Erdogan, who said the shot should be available for use by the end of the year.

Ankara currently administers vaccines developed by Sinovac, as well as by Pfizer-BioNTech.

Turkey also granted an emergency use authorization for Russia's Sputnik V. People over 25 are eligible for the vaccine.

"It is not clear how long this disease will go on and how much mutation it will go through. It is critical that we have our own vaccine against this disease," Erdogan said during a Tuesday event to mark the inoculation of the first phase three volunteer with the vaccine, which uses an inactivated virus.
Turkey has sharply accelerated COVID-19 vaccinations, delivering more than one million a day last week and prompting hopes of a rebound in the economy and tourism sector.


To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.

Become a CBC Member

Join the conversationCreate account

Already have an account?